100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary documents £7.49   Add to cart

Summary

Summary documents

 2 views  0 purchase

Everything you need to know for the exam summarized in one document and table

Preview 3 out of 27  pages

  • July 6, 2021
  • 27
  • 2020/2021
  • Summary
All documents for this subject (2)
avatar-seller
ashleyhundal
Asthma
 Pathophysiology
o Atopic asthma: high levels of Ige and specific Ab response to Ige. Produce Ige to
common environmental allergens like dust mites, animal proteins and fungi. Ige
activates mast cells and produces a power inflammatory reaction (macrophages
in airway  present antigen to helper T cells  activate and secret cytokines
ige production Ige binds to mast cells degranulation of mast cells releases
histamine, proteases, neutrophils and eosinophils which prolongs allergic
response
o Non-atopic asthma: later in life, imbalance between PNS and SNS. PNS releases
Ach and causes bronchoconstriction. SNS stimulates mast cells and produces a
powerful inflammatory reaction
o Inflammatory response
o Characterised by inflammation (Mucosal oedema), bronchospasms, sputum
production, chronic inflammation and remodelling
o Chronic inflammation and remodelling: hypertrophy of smooth muscle,
hyperplasia of mucus glands, thickening of basement membrane
o Status asmaticus: unresponsive to therapy, PEFR<50%
o Brittle asmaticus: can get unprovoked attacks, carry epipen
 Clinical features: SOB, wheeze, cough (if exacerbation, irritant receptors), mucus
production (usually exacerbation), decreased exercise tolerance, chest tightness,
hyperinflated, hypoventilation
 Auscultation: wheeze, reduced BS
 Chest xray: hyperinflated (10th or 11th rib touching diaphragm)
 Other investigations:
o ABG
o Lung function tests:
 FEV1/FVC <40% would be severe impairment
 PEFR: breathe out as hard and as fast as they can
 Medical Management
o Bronchodilators: SABA e.g. salbutamol+ventolin, LABA e.g. salmeterol+
serevent, SAMA e.g., ipratropium bromide+ Atrovent, LAMA e.g. Spiriva+
tiatropium bromide
o Steroids e.g. budesonide+ pulmicort
o flu vaccine
o O2 therapy
o Ventilation: PaO2<6.5, patient exhaustion, hypotension (systolic <90), resp. or
cardiac arrest
 Physiotherapy Management
o Positioning to maximize V/Q mismatch: side lying will preferentially ventilate the
dependent lung, relieve breathlessness
o ACBT

, o IPPB (if fatigued, will passively give patient a breath)
o Relaxation techniques
o Education: exercise will release catecholamines to open airways
** a lot of smokers not likely to see GP, think they have smokers cough
**60-80% FEV1 is mild COPD, <40% FEV1 is severe COPD
COPD: Emphysema
 Patho:
o A disease in alveoli with permanent enlargement of distal air spaces due to
protein breakdown of alveolar septa and destruction of elastic fibres. Formation
of bullae where alveoli join together Loss of radian traction causes airways to
become floppy and get elastic recoil of the airways which airway collapse on
expiration
o Mainly related to smoking and small percentage (2-3%) is related to alpha 1
antitrypsin deficiency which inhibits the action of elastase which destroys elastin.
Signs of genetic cause are that they usually develop it younger
o Secondary effects: airflow obstruction, increased airway resistance, increased
WOB, less surface area for gas exchange (isolates from chronic bronchitis), V/Q
mismatch

 Clinical features: SOB, wheeze, cough, decreased exercise tolerance, chest tightness,
hyperinflated, hypoventilation, history of smoking, chest tightness
 PT problems: reduced TV, V/Q mismatch, increased WOB, breathlessness, pursed lip
breathing, fixed ULs, use of accessory muscles, poor gas exchange
 Auscultation: reduced breathe sounds, wheeze (polyphonic)
 Chest xray: hyperinflated, long/thin heart, black lung fields, horizontal ribs, bullae (large
black region)
 Medical management: LTOT (if <7.3), diuretics (RVF), flu vaccine
o Smoking cessation program: 4 times more likely to quit (ASK,ADVISE, ACT)
 Surgical options: LVRS (remove a part of overexpanded lung) to remove bullae which
will relieve compression, reuces lung volume and allows doming (rising) of diphragm.
Reduces WOB, reduces V/Q mismatch
 Risk factors: RVF due to HPVC which increases pulmonary hypertension and can cause
heart failure. Signs could be ankle oedema and raised jugular venous pressure.
 PT management: education about smoking cessation, breathlessness management,
importance of exercise (pulmonary rehab), positions of ease **don’t use IPPB if bullae
 with acute exacerbation: could acute on chornic: similar to respiratory acidosis w/
partial compensation
 If CO2 levels rise after checking ABG following oxygen therapy, switch to NIV like a
facemask b/c increases TV and gets rid of excess CO2


COPD: Chronic Bronchitis
 Pathophysiology:

, o Chronic inflammation of the airways, insidious onset with morning cough
(smoker’s cough)
o Characterized by productive cough for three months for two consecutive years
o Possible causes: environtal pollutants, smoking (Main), occupational exposure,
repeated bronchial infections
o Inhalation of pollutants (usually smoke) causes irritation of the mucosa lining
airways
o Narrowing is secondary to mucosal eodmea, smooth muscle hypertrophy and
periobronchial fibrosis. Excessive bronchial secretions due to hypertrophy and
hyperplasia of goblet cells which causes increased mucus production, reduces
function of cilia and repeated infections can occur.
 Clinical features:: SOB, wheeze, productive cough, mucus production, decreased
exercise tolerance, hypoventilation, history of recurrent chest infections, history of
smoking, chest tightness
o Secondary effects: airway obstruction, increased airway resistance, increased
WOB, V/Q mismatch, impaired gas exchange
 Auscultation: inspiratory crackles due to sputum, wheeze (sputum can cause wheeze)
 Chest xray: consolidation if infected, patchy shadowing, increased hilar shadowing
(pulmonary hypertension), increased cardiac shadow
 Pharmacology: bronchodilators (If reversibility shown), steroids, flu vaccine, antibiotics,
diuretics (RVF)
 PT treatment: Education about smoking cessation, breathlessness management,
pulmonary rehabilitation, sputum clearance techniques if appropriate




Bronchiectasis
 Patho:
o Bronchiectasis is chronic and permanent widening of the airways and
destruction of bronchial wall, elastic content, blood vessels, cartilage, smooth
muscle. Results in decreased Mucoiciliary clearance and retained secretions,
making patients susceptible to recurrent infections and infection cause further
damage. Some possible causes of bronchiectasis: 53% idiopathic, 29% post
infectious
 Post-infection: measles, TB, whooping cough
 Immune defects: hypogammaglobulinemia because it normally produced
antibody response
 Allergic bronchopulmonary aspergillos: increased response to aspergillus
which is a fungi, become wheezy

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller ashleyhundal. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £7.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

60281 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£7.49
  • (0)
  Add to cart